Newsmeme!
Discover News you didn't know existed
Stem cell researchers Chad Cowan, Douglas Melton, and Alan Trounson joined Jeanne Loring in issuing statements against the University of Wisconsin's three human stem cell patents, says a Science news story.
NEW YORK (GenomeWeb News) – In a paper scheduled to appear online this week in the Proceedings of the National Academy of Sciences , researchers from the Genome Institute of Singapore and Wayne State University used a genome-wide screen to try to fish out primate-specific sequences in the human genome.
NEW YORK (Reuters Health) - There may be an association between high birth weight and an increased risk of overall leukemia and acute lymphoblastic leukemia (ALL). The increased risk of acute myeloid leukemia (AML) appears to be associated with the high and low extremes of birth weight.
The ex-wife of Michael Jackson plans to fight for custody of the two children she had with the tragic pop singer.The news comes as concert promoter AEG Live announces a public memorial will be held in LA next week.
The ex-wife of Michael Jackson plans to fight for custody of the two children she had with the tragic pop singer.
Price competition is coming to the rarified world of genome sequencing.
NEW YORK (GenomeWeb News) – BlueGnome will market Rubicon Genomics' technology along with its microarray-based aneuploidy chromosome screening and detection systems under a new non-exclusive agreement, Rubicon said today.
The 2009 Neuroscience Prize of The Peter and Patricia Gruber Foundation is being awarded to Jeffrey Hall, professor of neurogenetics at the University of Maine; Michael Rosbash, professor and director of the National Center for Behavioral Genomics at Brandeis University; and Michael Young, professor and head of the Laboratory of Genetics at Rockefeller University.
A trio of researchers from Pennsylvania State University used an approach called wavelet transformation analyses, among other methods, to investigate how local DNA sequence patterns relate to insertions and deletions in the non-coding, non-repeat regions of the human genome.
AstraZeneca announced that it has received a licence by the European Medicines Agency (EMEA) for its oral targeted anti-cancer drug, gefitinib, for EGFR (epidermal growth factor receptor-tyrosine kinase) activating mutation positive patients with Non Small Cell Lung Cancer (NSCLC). NSCLC is the most common type of lung cancer and accounts for 80% of all lung cancer cases.
Related News Resources:
> HGH News
|
Breaking News
and Top Stories |
Business
Earnings, Economy, Personal Finance, and Stock Markets |
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre |
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss |
Politics
Congress, Supreme Court, and White House |
|
Science
Animals, Astronomy, Biotechnology, Space, and Weather |
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis |
Technology
Communications, Hardware, Internet, Personal Technology, and Software |
United States
and Crimes and Trials |
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East |